Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle
about
Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucineInteractions between Autophagy and Bacterial Toxins: Targets for Therapy?Cerium oxide nanoparticle treatment ameliorates peritonitis-induced diaphragm dysfunctionActivated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patientsSalutary effect of aurintricarboxylic acid on endotoxin- and sepsis-induced changes in muscle protein synthesis and inflammationSkeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis.BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic mice.Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesisRegulation of muscle protein synthesis during sepsis and inflammation.Cyclin alterations in diverse cancers: Outcome and co-amplification network.Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes.Glucocorticoids and TNFalpha interact cooperatively to mediate sepsis-induced leucine resistance in skeletal muscle.Feeding critically ill patients the right 'whey': thinking outside of the box. A personal view.Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?Endotoxin and interferon-gamma inhibit translation in skeletal muscle cells by stimulating nitric oxide synthase activitymTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?Oxytocin modulates mTORC1 pathway in the gut.Calpain activity and muscle wasting in sepsisActivation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside prevents leucine-stimulated protein synthesis in rat skeletal muscle.Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling.Local insulin-like growth factor I prevents sepsis-induced muscle atrophy.Marginal dietary zinc deprivation augments sepsis-induced alterations in skeletal muscle TNF-α but not protein synthesis.Castration differentially alters basal and leucine-stimulated tissue protein synthesis in skeletal muscle and adipose tissue.Bench-to-bedside review: Beta-adrenergic modulation in sepsis.New perspectives in the control of body protein metabolism.The emerging role of mTOR signalling in antibacterial immunity.A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction.Leucine stimulates ASCT2 amino acid transporter expression in porcine jejunal epithelial cell line (IPEC-J2) through PI3K/Akt/mTOR and ERK signaling pathways.Endotoxin transiently inhibits protein synthesis through Akt and MAPK mediating pathways in C2C12 myotubes.Leucine supplementation stimulates protein synthesis and reduces degradation signal activation in muscle of newborn pigs during acute endotoxemia.Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.Glycine restores the anabolic response to leucine in a mouse model of acute inflammation.Elevated plasma free fatty acids decrease basal protein synthesis, but not the anabolic effect of leucine, in skeletal muscle.Intestinal ribosomal p70(S6K) signaling is increased in piglet rotavirus enteritis.Insulin stimulates muscle protein synthesis in neonates during endotoxemia despite repression of translation initiation.Amino acids augment muscle protein synthesis in neonatal pigs during acute endotoxemia by stimulating mTOR-dependent translation initiation.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Effect of supplemental dietary leucine and immune system stimulation on whole-body nitrogen utilization in starter pigs.Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements.
P2860
Q24633679-FD8C8666-818E-4BAB-A4A2-07829F575C28Q26801464-3C47B534-7BAA-4D2A-86FE-0396562CF500Q28390788-936E1F23-5647-42BD-B5E9-71C9EEC322ADQ33869877-19B829BD-437D-4EB2-AA1D-F40D91048599Q33901148-7B6AB173-0680-483F-A8A6-520134F7D40DQ34137976-81F30E01-5D4F-4FB3-AE4E-E5379E0DFCC4Q34150233-40156E86-3546-41CE-B7B3-FD9B36FE803CQ34293717-52996831-D58F-438A-BF8E-192C5EAE6F5DQ34372599-E925EBEB-CFE5-4EAF-82E3-07BEA6B181F7Q34628735-412F1219-00E7-4B59-9039-BD31E9354091Q35550165-791F135B-B709-4113-A9D0-79ABB4347C96Q35558447-2CA6DD43-B634-48DB-8444-DC8F12848C0AQ35690899-473D2682-6FD4-43E5-8AC5-968CD78C0566Q35697448-BEA5AD5C-120E-4225-867C-2B21465E14CAQ35835983-97EAE768-A81E-4497-AB77-54BC48D3EE35Q35880345-08B42704-B89D-4FF4-855D-7FF0B2779AEAQ36711877-F8FE6034-F706-4B88-BBC6-5755EF724EBEQ36746634-34CF3F24-16F0-497D-86C7-8A3B763D5503Q36956035-0CBB006C-560E-4DA4-883D-E6DB05B6D54BQ37000863-E6B13488-753C-42AA-8CFB-A663C91BF8CBQ37374064-AA8E19ED-D13B-491F-85A5-15A3501C0CF3Q37381871-D4617B4E-D8D4-47D9-88D8-C591D5046403Q37419009-3067808B-1DFD-4CB4-B121-8F02610B7A14Q37430776-1A452C36-3E2E-4428-B447-4415DFA58BFDQ37623067-D9B2EE56-1346-40D1-BEFD-2C55235DAB4DQ38056271-AB81C42B-3A3D-44CD-95E5-7459D037D228Q38187336-9EC2CFA4-7399-4CDD-AF20-1B996D6D5D19Q38964540-ECFEF69C-F813-4019-97B8-DCDC645BEC19Q38971572-A8A37F80-7127-46DA-84E5-5F6BF8302209Q39503456-56F30084-780A-4A0F-91D5-E3D0806E0937Q40541664-22C14CFB-3071-4D17-A56B-DBEFCF4FBF5CQ42011965-01527461-AB50-4B8D-8C63-7911298CC2E3Q42492063-62E4DD23-2820-4FC4-8E23-EC9D6A08EAE6Q42495077-09067D75-CA35-4590-A525-C23B0AC6CDE1Q44745867-A3A09576-5824-41D5-8A9A-D978121D9065Q44820248-58F7F412-EF21-464E-8859-BB4DC003B31CQ44861027-DA2334CE-A059-4BFF-9179-7129B0478E6AQ48155681-629EC877-6AE3-43A5-921B-FEA571B35ACEQ51709754-11CC8405-E16C-459C-9E68-C0665C264E3BQ55239168-46B3D322-7639-4390-88C2-05545CA3E97C
P2860
Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle
description
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im April 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/04/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/04/01)
@nl
наукова стаття, опублікована у квітні 2005
@uk
مقالة علمية (نشرت في أبريل 2005)
@ar
name
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@ast
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@en
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@nl
type
label
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@ast
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@en
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@nl
prefLabel
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@ast
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@en
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@nl
P2860
P356
P1476
Endotoxin disrupts the leucine ...... 1, and S6K1 in skeletal muscle
@en
P2093
Charles H. Lang
Robert A. Frost
P2860
P304
P356
10.1002/JCP.20207
P577
2005-04-01T00:00:00Z